Impedimed

ImpediMed Ltd is an Australian company and a global provider of medical technology for non-invasively measuring, monitoring and managing body fluid and tissue status.
image004-1

The system uses proprietary bioimpedance spectroscopy (BIS) technology and allows for monitoring throughout the patient’s journey, tracking fluid status and lymphoedema.

The aim of ImpediMed is to leave no patient untested.

The new SOZO™ platform monitors fluid status for patients during care and it also provides assessment of lymphoedema using L-Dex® post-surgery.

SOZO™ can also monitor patient hydration and analyse patient tissue composition.

The technology gathers and retains thousands of unique data points related to fluid status and tissue analysis to quickly and accurately create individualized cross functional baseline readings for every patient.

The SOZO™ device is designed for use in hospitals, clinics and medical centres under a clinician’s direction.

The measurement outputs from SOZO™ have the power to transform proactive care by providing easy access to more complete information regarding a patient’s clinical care.

The SOZO™ provides access to current and historical data for individual and population trend analysis and easily integrates into existing workflow practice and systems.

It is a non-invasive fluid and tissue analysis device which offers the following benefits to patients:

• An easy to use device that enables early detection of fluid accumulation in the body
• It uses bio-impedance spectroscopy to analyse and detect changes in body composition (fat and muscle mass)
• It can be used to detect early stages of lymphoedema
• It also offers objective measurement of body fluid status
• Data analysis and trends
• Hydration & Body fluid status

More information is available at the following website.